Publication: 284

Publication: 284

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 27 (12) 2052-2058

Year:: 2009
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 486 502 825
Children:: None

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:: P30 CA015083, U10 CA025224, P30 CA15083, U10 CA25224

Corr. Author:
Authors:: Evanthia Galanis Kurt A. Jaeckle Matthew J. Maurer Joel M. Reid Matthew M. Ames James S. Hardwick John F. Reilly Andrey Loboda Michael Nebozhyn Valeria R. Fantin Victoria M. Richon Bernd Scheithauer Caterina Giannini Patrick J. Flynn Dennis F. Moore James Zwiebel Jan C. Buckner

Networks:

Study: NCCTG-N047B
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: Bios3, Neur1, Original Reports, Neurooncology